Cornelis Alexander Izeboud
Director/Board Member chez TME PHARMA N.V.
Profil
Cornelis Alexander Izeboud is currently the Chief Executive Officer and Executive Director at Scenic Biotech BV.
He also holds non-executive director and independent member-supervisory board positions at NOMAD Bioscience GmbH and TME Pharma NV respectively.
Previously, he held managing director positions at Van Lanschot Kempen NV and NIBC Bank NV.
He was also a non-executive director at Luciole Medical AG.
Dr. Izeboud obtained a doctorate degree from the University of Utrecht.
Postes actifs de Cornelis Alexander Izeboud
| Sociétés | Poste | Début |
|---|---|---|
| TME PHARMA N.V. | Director/Board Member | 30/06/2020 |
Scenic Biotech BV
 Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Chief Executive Officer | - |
NOMAD Bioscience GmbH
 NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Director/Board Member | 01/04/2020 |
Anciens postes connus de Cornelis Alexander Izeboud
| Sociétés | Poste | Fin |
|---|---|---|
| NIBC Bank NV (Research Firm) | Analyst-Equity | 01/07/2020 |
Luciole Medical AG
 Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Director/Board Member | - |
Van Lanschot Kempen NV (Broker)
 Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Analyst-Equity | - |
Formation de Cornelis Alexander Izeboud
| University of Utrecht | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Van Lanschot Kempen NV (Broker)
Van Lanschot Kempen NV (Broker) Investment Banks/BrokersFinance Van Lanschot Kempen NV (Broker) (Van Lanschot Kempen-Broker) is the broker-dealer division of Van Lanschot Kempen NV (AMS: VLK), a financial institution headquartered in Amsterdam, Netherlands. The firm was founded in 1903 and formerly known as Kempen & Co. NV. Van Lanschot Kempen-Broker provides securities broking to institutional investors, companies, financial institutions, (semi) public institutions, foundations and high net-worth individual clients. | Finance |
NOMAD Bioscience GmbH
NOMAD Bioscience GmbH BiotechnologyHealth Technology NOMAD Bioscience GmbH provides research and development services in the field of biomaterials. It holds interests in the biotechnologies, biogas, biofuel, and medicinal products. The company was founded by Yuri Gleba in 2008 and is headquartered in Munich, Germany. | Health Technology |
| NIBC Bank NV (Research Firm) | Finance |
Scenic Biotech BV
Scenic Biotech BV Miscellaneous Commercial ServicesCommercial Services Scenic Biotech BV is using genomics to develop innovative therapies for patients affected by severe diseases. The company was founded by Thijn Brummelkamp and Sebastian Nijman and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Luciole Medical AG
Luciole Medical AG Packaged SoftwareTechnology Services Luciole Medical AG operates as a Swiss medical technology company developing brain oxygenation monitoring systems. The firm's products include Rheopatch, RheoSens, RheoLity and RheoControl. The company was founded in September 2017 and is headquartered in Zurich, Switzerland. | Technology Services |
